Özgür Doğuş Erol

6PUBLICATIONS
17CO-AUTHORS
Molecular targetsRegenerative medicine (incl. stem cells)Immunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 11, 2025
Assessment of Potential Side Effects Related To RAB27A Gene Therapy in Stem Cells.

Özgür Doğuş Erol, Mehmet Emin Şeker, Şimal Şenocak

|Mar 12, 2025
Endocannabinoid system upregulates the enrichment and differentiation of human iPSC- derived spermatogonial stem cells via CB2R agonism.

Merve Gizer, Selin Önen, Özgür Doğuş Erol

|Oct 30, 2024
Correction of Griscelli Syndrome Type 2 causing mutations in the RAB27A gene with CRISPR/Cas9.

Özgür Doğuş Erol, Şimal Şenocak, Burcu Özçimen

|Oct 26, 2024
Assessment of non-myelotoxic agents as a preparatory regimen for hematopoietic stem cell gene therapy.

Mehmet Emin Şeker, Özgür Doğuş Erol, Burcu Pervin

|May 14, 2024
Bone marrow mesenchymal stromal cells support regeneration of intestinal damage in a colitis mouse model, independent of their CXCR4 expression.

Burcu Pervin, Merve Gizer, Mehmet Emin Şeker

|Apr 15, 2023
The Role of Rab GTPases in the development of genetic and malignant diseases.

Özgür Doğuş Erol, Şimal Şenocak, Fatima Aerts-Kaya

Pageof 1

Frequent Collaborators

5 joint publications

Fatima Aerts-Kaya

3 joint publications

Şimal Şenocak

3 joint publications

Merve Gizer

3 joint publications

Mehmet Emin Şeker